KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $233.0 million.

  • Charles River Laboratories International's Capital Expenditures fell 8.11% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.8 million, marking a year-over-year decrease of 12.67%. This contributed to the annual value of $233.0 million for FY2024, which is 26.86% down from last year.
  • Per Charles River Laboratories International's latest filing, its Capital Expenditures stood at $233.0 million for FY2024, which was down 26.86% from $318.5 million recorded in FY2023.
  • Charles River Laboratories International's Capital Expenditures' 5-year high stood at $324.7 million during FY2022, with a 5-year trough of $166.6 million in FY2020.
  • Its 3-year average for Capital Expenditures is $292.1 million, with a median of $318.5 million in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 41.95% in 2022, then dropped by 26.86% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Capital Expenditures (Yearly) stood at $166.6 million in 2020, then skyrocketed by 37.35% to $228.8 million in 2021, then spiked by 41.95% to $324.7 million in 2022, then dropped by 1.91% to $318.5 million in 2023, then decreased by 26.86% to $233.0 million in 2024.